Objectives:

  1. Discuss tumor-intrinsic mechanisms of immune response and resistance
  2. Discuss current work examining the role of tumor-cell-intrinsic HIF1a activation in mediating immune evasion and resistance to immunotherapy
  3. Discuss current work investigating whether WNT/β-catenin activation mediates immune resistance in mismatch-repair deficient tumors
Session date: 
Monday, December 10, 2018 - 12:00pm to 1:00pm
Speaker Name: 
Jonathan A. Trujillo, MD, PhD
Location: 
UCMC
5841 South Maryland Avenue
MC2115, HemOnc Conference Room E215
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.